Cisplatin otoprotection using transtympanic L-N-acetylcysteine: a pilot randomized study in head and neck cancer patients.
about
Oxidative Stress and Inflammation in Hepatic Diseases: Therapeutic Possibilities of N-AcetylcysteinePrevention and restoration of hearing loss associated with the use of cisplatin.N-acetyl-cysteine prevents age-related hearing loss and the progressive loss of inner hair cells in γ-glutamyl transferase 1 deficient mice.Ups and downs of Viagra: revisiting ototoxicity in the mouse model.Apaf-1 inhibitors protect from unwanted cell death in in vivo models of kidney ischemia and chemotherapy induced ototoxicityIn vitro efficacy of N-acetylcysteine on bacteria associated with chronic suppurative otitis mediaEarly investigational drugs for hearing loss.The Protective Effect of Chrysin Against Cisplatin İnduced Ototoxicity in Rats.N-Acetyl-l-Cysteine and Cysteamine as New Strategies against Mixed Biofilms of Nonencapsulated Streptococcus pneumoniae and Nontypeable Haemophilus influenzae.Cisplatin-induced mitochondrial dysfunction is associated with impaired cognitive function in rats.Molecular basis of hair cell loss.A systematic review and meta-analysis of the efficacy and safety of N-acetylcysteine in preventing aminoglycoside-induced ototoxicity: implications for the treatment of multidrug-resistant TB.Potentiation of chemotherapeutics by bromelain and N-acetylcysteine: sequential and combination therapy of gastrointestinal cancer cells.Bromelain and N-acetylcysteine inhibit proliferation and survival of gastrointestinal cancer cells in vitro: significance of combination therapy.Paradoxical roles of dual oxidases in cancer biology.Evidence of the presence of nucleic acids and β-glucan in the matrix of non-typeable Haemophilus influenzae in vitro biofilms.Dose escalation study of intravenous and intra-arterial N-acetylcysteine for the prevention of oto- and nephrotoxicity of cisplatin with a contrast-induced nephropathy model in patients with renal insufficiency.Protein Synthesis Inhibition and Activation of the c-Jun N-Terminal Kinase Are Potential Contributors to Cisplatin Ototoxicity.Targeted amelioration of cisplatin-induced ototoxicity in guinea pigs.Progress in the Development of Preventative Drugs for Cisplatin-Induced Hearing Loss.The Development of a Nano-based Approach to Alleviate Cisplatin-Induced Ototoxicity.Biological Activities and Potential Oral Applications of N-Acetylcysteine: Progress and Prospects.Preparing for the incoming wave of biosimilars in oncology
P2860
Q26773384-A561D8CD-D974-46D7-BDE7-F579B6755A89Q26825493-0DD39999-235A-43BF-8249-32193FE3A4A9Q28397956-DAF7B179-3A01-41F9-8CEE-C7DBD0AED7CFQ28535147-95EB6E9F-7DC4-418F-BB09-DD2B9AF92FE4Q28543956-B2F18D02-492D-45A1-877B-985D56E58476Q30434847-633CA4C8-3FB2-461E-A8F3-13707E12E160Q33847686-76929FF6-534C-4B62-AFFB-B84D0A78A260Q36064041-222C5A9F-8772-403C-9FD5-8A24AA3B81E4Q36213831-4F9EE8FE-C246-4CCD-8119-FC98218E7D68Q37641278-23E60D0C-BF56-4142-9916-8127DE7F4804Q38353200-DEC72EFA-782A-42CD-BF0A-108E839A7958Q38582633-1E01D70A-1A1C-4968-8064-8824E51AA8C7Q38866435-FCC31D59-E318-48F2-AE6E-ACA9EE272F71Q38937722-D6F56B11-13B0-4282-BACE-DB286E6DD4A7Q39348472-00C839C0-D8D5-4212-BFC2-8A806938F33AQ40470161-D27AFBE0-691D-434F-9141-E937E44444C8Q42281143-A23CA1F9-01D7-48E7-8945-AE0369199C58Q42369948-3AE29474-F075-4355-AA6F-789ED344AC41Q46941571-687E6B6A-F3B6-4028-8F89-49EB33A03855Q47716828-236599D6-A3E1-4770-A028-88A896223573Q49936568-4A1ADA0A-CB09-456B-8D7E-E8A2297940E7Q54698100-E36F8CF7-FBDE-44FD-B63B-2A3E861E033DQ58762727-726F5D18-3501-4D22-8BD1-C307E64CA095
P2860
Cisplatin otoprotection using transtympanic L-N-acetylcysteine: a pilot randomized study in head and neck cancer patients.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Cisplatin otoprotection using ...... head and neck cancer patients.
@en
Cisplatin otoprotection using ...... head and neck cancer patients.
@nl
type
label
Cisplatin otoprotection using ...... head and neck cancer patients.
@en
Cisplatin otoprotection using ...... head and neck cancer patients.
@nl
prefLabel
Cisplatin otoprotection using ...... head and neck cancer patients.
@en
Cisplatin otoprotection using ...... head and neck cancer patients.
@nl
P2093
P2860
P356
P1433
P1476
Cisplatin otoprotection using ...... head and neck cancer patients.
@en
P2093
Denise Lewis
Douglas Angel
Eric Winquist
Jason Franklin
Kevin Fung
Lorne S Parnes
Scott J Hamilton
Varagur Venkatesan
P2860
P304
P356
10.1002/LARY.24360
P407
P577
2013-10-01T00:00:00Z